Hospitals and universities taking control of patient reimbursements

23 November 2016

Hospitals and universities participate in clinical research to advance science and get actively involved with the development of new and innovative treatments, writes Zach Hales, ClinCard product manager at Greenphire, in an expert view piece.

Clinical research is very successful in the hospital or university setting because there is a high recruitment population right at their fingertips. Patients are at an advantage, as they are getting access to new treatments and healthcare that may not be available to them.

However, recruiting and keeping patients engaged is not always so simple. In fact, according to the Center for Information and Study on Clinical Research Participation:

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK